135 related articles for article (PubMed ID: 6362203)
1. Comparison of two therapeutic regimens using the same topical corticoid for stable psoriasis.
Senter TP; Stimson DH; Charles G; Brand RJ
West J Med; 1983 Nov; 139(5):657-62. PubMed ID: 6362203
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of desoximetasone ointment 0.25% versus fluocinonide ointment 0.05% in patients with psoriasis.
Clin Ther; 1985; 8(1):118-25. PubMed ID: 3914368
[TBL] [Abstract][Full Text] [Related]
3. Clobetasol propionate ointment once daily versus fluocinonide ointment three times daily in psoriasis.
Bickers D; Cornell R; Kamm AR; Bauman WE; Handler RM; Medansky RS; Sturm HM
Int J Dermatol; 1988; 27(1):54-5. PubMed ID: 3278991
[No Abstract] [Full Text] [Related]
4. Comparison of amcinonide ointment 0.1 percent twice daily and fluocinonide ointment 0.05 percent three times daily in the treatment of psoriasis.
Cornell RC
Cutis; 1983 May; 31(5):566-9. PubMed ID: 6851655
[TBL] [Abstract][Full Text] [Related]
5. Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasis.
Willis I; Cornell RC; Penneys NS; Zaias N
Clin Ther; 1986; 8(3):275-82. PubMed ID: 3521856
[TBL] [Abstract][Full Text] [Related]
6. Treatment of psoriasis with amcinonide 0.1 percent and fluocinonide 0.05 percent ointments. A comparative double-blind study.
Engel MF
Cutis; 1982 Jun; 29(6):646-50. PubMed ID: 7049592
[TBL] [Abstract][Full Text] [Related]
7. Fluocinonide compared with betamethasone in the treatment of eczema and psoriasis.
Ronn HH
Practitioner; 1976 Jun; 216(1296):704-6. PubMed ID: 781661
[TBL] [Abstract][Full Text] [Related]
8. Clinical trial of a potent non-halogenated topical steroid, Budesonide.
Agrup G; Björnberg A; Elmros T; Groth O; Hannuksela M; Lassus A; Salde L; Skogh M; Thomsen K
Acta Derm Venereol; 1981; 61(2):180-2. PubMed ID: 6165205
[TBL] [Abstract][Full Text] [Related]
9. Preliminary clinical evaluation of a new topical corticosteroid, halopredone acetate, as compared to fluocinonide.
Rampini E; Rastelli A; Divano C
Arzneimittelforschung; 1977; 27(12):2396-9. PubMed ID: 341903
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis: topical corticosteroid therapy.
Lynfield Y; Watsky M
Cutis; 1976 Jul; 18(1):133, 136-7. PubMed ID: 797547
[TBL] [Abstract][Full Text] [Related]
11. Topical fluocinonide and tachyphylaxis.
Senter TP
Arch Dermatol; 1983 May; 119(5):363-4. PubMed ID: 6847210
[No Abstract] [Full Text] [Related]
12. Double-blind comparison of topical halcinonide and fluocinonide in the treatment of psoriasis.
Close JE
Int J Dermatol; 1976 Sep; 15(7):534-7. PubMed ID: 786910
[No Abstract] [Full Text] [Related]
13. Treatment of refractory psoriasis with fluocinonide gel.
Willoughby CB; Cook WR
Cutis; 1977 Jul; 20(1):144-5. PubMed ID: 884957
[TBL] [Abstract][Full Text] [Related]
14. Clobetasol propionate versus fluocinonide creams in psoriasis and eczema.
Jegasothy B; Jacobson C; Levine N; Millikan L; Olsen E; Pinnell S; Cole G; Weinstein G; Porter M
Int J Dermatol; 1985 Sep; 24(7):461-5. PubMed ID: 3902682
[TBL] [Abstract][Full Text] [Related]
15. [Topical treatment of dermatoses with difluocortolone valerate fatty ointment].
Carvajal Rosado VM
Z Hautkr; 1976; 51 Suppl 1():27-9. PubMed ID: 795183
[TBL] [Abstract][Full Text] [Related]
16. Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
Shimao S
J Dermatol; 1979 Dec; 6(6):383-90. PubMed ID: 396316
[No Abstract] [Full Text] [Related]
17. Comparison of 0.25% desoxymethasone ointment with 0.05% fluocinonide ointment in psoriasis.
Kuokkanen K
Curr Med Res Opin; 1976-1977; 4(10):703-5. PubMed ID: 800971
[TBL] [Abstract][Full Text] [Related]
18. Double-blind comparison of a dithranol and steroid mixture with a conventional dithranol regimen for chronic psoriasis.
Grattan CE; Christopher AP; Robinson M; Cowan MA
Br J Dermatol; 1988 Nov; 119(5):623-6. PubMed ID: 3061441
[TBL] [Abstract][Full Text] [Related]
19. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases.
Lozada F; Silverman S
Arch Dermatol; 1980 Aug; 116(8):898-901. PubMed ID: 6996618
[TBL] [Abstract][Full Text] [Related]
20. Halometasone cream by day and halometasone ointment at night for the treatment of patients with chronic psoriasis vulgaris.
Galbiati G; Bonfacini V; Candiani F
J Int Med Res; 1983; 11 Suppl 1():31-3. PubMed ID: 6339290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
